DENTSPLY SIRONA Inc header image

DENTSPLY SIRONA Inc

XRAY

Equity

ISIN null / Valor 31773200

NASDAQ (2026-08-06)
USD 13.17-4.43%

DENTSPLY SIRONA Inc
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

DENTSPLY SIRONA Inc is a global leader in the manufacturing of professional dental products and technologies, working in collaboration with partners to develop innovative solutions for dental professionals worldwide. With a mission to transform dentistry and improve oral health on a global scale, the company is dedicated to empowering dental practices, clinics, laboratories, and distributors to deliver top-quality dental care to patients. DENTSPLY SIRONA's research division plays a key role in driving the development of next-generation dental solutions, reflecting the company's commitment to advancing the field of dentistry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-3.73%1Y
-66.5%3Y
-78.2%5Y

Performance

45.0%1Y
42.0%3Y
38.6%5Y

Volatility

Market cap

2638 M

Market cap (USD)

Daily traded volume (Shares)

5,506,576

Daily traded volume (Shares)

1 day high/low

18.86 / 18.36

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Matthew Tombaugh
Switzerland, 23 Mar 2026
star star star star star
A textbook deep value play. The stock is priced for failure at 8.9x earnings, but management is at the 10-yard line of a turnaround. Cutting the dividend to buy back shares at these depressed levels is a aggressive, shareholder-friendly move.

EQUITIES OF THE SAME SECTOR

BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.99%USD 82.80
Alkem Laboratories Ltd.
Alkem Laboratories Ltd. Alkem Laboratories Ltd. Valor: 30689895
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%INR 5,608.45
Insmed Inc
Insmed Inc Insmed Inc Valor: 12614415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
33.86%USD 132.55
Laurus Labs Ltd.
Laurus Labs Ltd. Laurus Labs Ltd. Valor: 56464789
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%INR 1,836.00
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.27%INR 834.60
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Ltd. Narayana Hrudayalaya Ltd. Valor: 30795490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.98%INR 1,883.80
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.76%INR 562.55
Cohance Lifesciences Ltd
Cohance Lifesciences Ltd Cohance Lifesciences Ltd Valor: 46346459
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.54%INR 439.85
Gland Pharma Ltd.
Gland Pharma Ltd. Gland Pharma Ltd. Valor: 56038514
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.82%INR 2,617.50
MEDICLIN AG
MEDICLIN AG MEDICLIN AG Valor: 1158721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.31%EUR 4.22